Increased prevalence of factor V Leiden mutation in neonatal intracranial haemorrhage
Melegh, B.; Stankovics, J.; Kis, A.; Nagy, A.; Storcz, J.; Losonczy, H.; Méhes, K.
European Journal of Pediatrics 157(3): 261
1998
ISSN/ISBN: 0340-6199 PMID: 9537500 Document Number: 490450
Document emailed within 1 workday
Related Documents
Verheggen, P.W.; Heymans, B.T.; Slagboom, P.E.; Haverkate, F.; Cats, V.M. 1997: Normal prevalence of factor V Leiden gene mutation in patients with severe unstable angina Thrombosis and Haemostasis 77(6): 1218Cadroy, Y.; Sié, P.; Alhenc-Gelas, M.; Aiach, M. 1995: Evaluation of APC resistance in the plasma of patients with Q506 mutation of factor V (factor V Leiden) and treated by oral anticoagulants Thrombosis and Haemostasis 73(4): 734-735
Schröder, W.; Koessling, M.; Wulff, K.; Wehnert, M.; Herrmann, F.H. 1996: World distribution of factor V Leiden mutation Lancet 347(8993): 58-59
Fouéré, S.; Guibal, F.; Morel, P. 1996: World distribution of factor V Leiden mutation Lancet 347(8993): 59
Kotaka, M.; Kohchi, A. 2003: Perioperative management of a patient with factor V Leiden mutation Masui. Japanese Journal of Anesthesiology 52(4): 409-411
Yong, A.Anning.; Tan, A.Wei.Hsia.; Giam, Y.Chin.; Tang, M.Boon.Yang. 2012: Livedoid vasculopathy and its association with factor V Leiden mutation Singapore medical journal 53(12): e258-e260
Paseka, J.; Unzeitig, V.; Cibula, D.; Buliková, A.; Matýsková, M.; Chroust, K. 2000: The factor V Leiden mutation in users of hormonal contraceptives Ceska Gynekologie 65(3): 156-159
2001: Summaries for patients. Blood clots in people with the factor V Leiden mutation Annals of Internal Medicine 135(5): S-34
Morissette, N.; Gorman, T. 2010: Antiphospholipid syndrome and homozygous factor V Leiden mutation in a young patient with Libman-Sacks endocarditis and stroke American Journal of Medicine 123(9): E3-E4
Guan, X.J. 1985: Neonatal intracranial haemorrhage and causal analysis of the diagnostic errors; autopsies of 46 cases Zhonghua Fu Chan Ke Za Zhi 20(3): 175-177; 191
Narawane, N.M.; Phadke, A.Y.; Shah, S.K.; Bhandarkar, P.V.; Abraham, P. 2000: Jejunal stricture complicating acute mesenteric venous thrombosis secondary to protein C deficiency and factor V Leiden gene mutation Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 19(2): 79-80
Chuansumrit, A.; Jarutwachirakul, W.; Sasanakul, W.; Rurgkhum, S.; Tardtong, P.; Hathirat, P. 2001: Prevalence of factor V Leiden in Thai blood donors Journal of the Medical Association of Thailand 84(4): 489-493
Fuijkschot, J.; Antonius, T.; Meijers, P.W.; Vrancken, S. 2008: Neonatal subgaleal haemorrhage; a potential life-threatening extracranial haemorrhage Nederlands Tijdschrift Voor Geneeskunde 152(2): 96-100
Billon, S.; Escoffre-Barbe, M.; Mercier, B.; Abgrall, J.F.; Ferec, C. 1999: Fibrinogen is not an additional risk factor of thromboembolic disease in factor V Leiden patients Thrombosis and Haemostasis 81(4): 659-660
Bertina, R.M. 1997: Factor V Leiden and other coagulation factor mutations affecting thrombotic risk Clinical Chemistry 43(9): 1678-1683
Aksoy, M.; Tek, I.; Karabulut, H.; Berker, B.; Soylemez, F. 2005: The role of thrombofilia related to Factor V Leiden and Factor II G20210A mutations in recurrent abortions Jpma. Journal of the Pakistan Medical Association 55(3): 104-108
Hung, C.C.; Wang, D.J.; Kao, M.C.; Lin, S.M. 1979: Intracranial hemorrhage as a life-threatening complication of decompressive procedures for increased intracranial pressure Journal of the Formosan Medical Association 78(5): 460-469
Mracek, Z. 1978: Intracranial haemorrhage accompanying frontobasal injuries Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 45(3): 263-269
Chia, B.K.; Chong, W.S.; Tey, H.L. 2016: Generalised Anhidrosis Secondary to Intracranial Haemorrhage Annals of the Academy of Medicine Singapore 45(2): 69-70
Castoldi, E.; Kalafatis, M.; Lunghi, B.; Simioni, P.; Ioannou, P.A.; Petio, M.; Girolami, A.; Mann, K.G.; Bernardi, F. 1998: Molecular bases of pseudo-homozygous APC resistance: the compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma Thrombosis and Haemostasis 80(3): 403-406